Synovis Life Technologies, Inc. (NASDAQ:SYNO)

CAPS Rating: 3 out of 5

A diversified medical device company; develops, manufactures and markets products for the surgical and interventional treatment of disease. Business is conducted in two reportable segments, the surgical business and the interventional business.

Results 1 - 9 of 9

Recs

0
Member Avatar BeaterOfFools (< 20) Submitted: 3/13/2010 8:02:47 PM : Outperform Start Price: $14.77 SYNO Score: +75.03

Red Raider is Lord

Recs

0
Member Avatar jrjrook (< 20) Submitted: 5/28/2009 8:18:49 PM : Outperform Start Price: $17.62 SYNO Score: +12.95

SYNO to purchase Span-America Medical Systems, SPAN, ? Would

be a boon for both Co.s? M & A leads to growing co.s, market expansion.

Recs

0
Member Avatar lulamae12 (< 20) Submitted: 6/16/2008 3:27:37 PM : Outperform Start Price: $19.60 SYNO Score: +42.66

SYNO or Synovis Life Technologies, Inc.had a fourth quarter profit that helped this stock to rise and rise high! Their board of directors has also approved a buyback of One-Million stocks. Syno has at the current time about 12.4Million in outstanding stock. Part of this buy-back will be done on the open market and also through private sectors. Get this stock before it rises anymore. Personally, I'd rather have the "rise" in my bank account. How about You?

Recs

0
Member Avatar JohnnyiPhone (< 20) Submitted: 6/13/2008 8:40:10 AM : Outperform Start Price: $17.59 SYNO Score: +57.39

Member of the "Mini-Cap Monsters."

Recs

0
Member Avatar gilboy7 (< 20) Submitted: 5/28/2008 7:57:18 PM : Outperform Start Price: $19.80 SYNO Score: +42.93

great growth potential

Recs

0
Member Avatar viclyn509 (33.32) Submitted: 4/24/2008 6:46:17 PM : Outperform Start Price: $16.70 SYNO Score: +69.46

Their product "Veritas", for challenging abdominal wall and breast reconstruction

Recs

0
Member Avatar scrubs620 (< 20) Submitted: 12/5/2007 7:33:30 PM : Outperform Start Price: $22.33 SYNO Score: +32.32

Increase on 3 times normal volume to start right side of possible base. IBD

Recs

0
Member Avatar MNBOB (< 20) Submitted: 9/13/2007 3:32:37 PM : Outperform Start Price: $20.84 SYNO Score: +41.09

They have a prduct line that is the best in their market.

Recs

0
Member Avatar AGAPE1646 (< 20) Submitted: 5/11/2007 1:58:34 AM : Outperform Start Price: $12.78 SYNO Score: +125.91

SYNO has a solid balance sheet, important patents in microvascular devices, and no doebt. They can go to the markets for product launch/marketing cash when needed (end of 2007).

SYNO needs to lower SG&A expense and invest the savings in R&D.

They are a disruptor in microsurgical technology, and will either grow fast or be acquired.

Two year price target is $28-$30.

Results 1 - 9 of 9

Featured Broker Partners


Advertisement